Clinical trials
Pulmonary Arterial Hypertension trials in China with unknown status
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
16 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2009 | 1 |
| 2012 | 2 |
| 2013 | 2 |
| 2017 | 2 |
| 2018 | 1 |
| 2019 | 2 |
| 2020 | 2 |
| 2021 | 1 |
| 2022 | 2 |
| 2023 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Unknown status | 16 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| RenJi Hospital | 3 |
| Wuhan Asia Heart Hospital | 2 |
| Air Force Military Medical University, China | 1 |
| China National Center for Cardiovascular Diseases | 1 |
| Chinese Academy of Medical Sciences, Fuwai Hospital | 1 |
| Chinese Pulmonary Vascular Disease Research Group | 1 |
| Chinese SLE Treatment And Research Group | 1 |
| Gmax Biopharm LLC. | 1 |
| Hong Liu | 1 |
| Nanjing First Hospital, Nanjing Medical University | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Pulmonary Arterial Hypertension | 16 |
| Hypertension, Pulmonary | 2 |
| Cardiovascular Diseases | 1 |
| Death | 1 |
| Lung Diseases | 1 |
| Lupus Erythematosus, Systemic | 1 |
| Mitral Valve Insufficiency | 1 |
| Ventricular Dysfunction, Right | 1 |
Trials
Showing 1 to 16 of 16. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.